Home › Funds › GLENVIEW CAPITAL MANAGEMENT, LLC › CVS

GLENVIEW CAPITAL MANAGEMENT, LLC position in CVS

CVS HEALTH CORP · Consumer Staples

GLENVIEW CAPITAL MANAGEMENT, LLC reported holding 4,824,799 shares of CVS (CVS HEALTH CORP) in its Q2 2026 13F filing — a position valued at US$499.1M, representing 9.54% of its reported portfolio and ranking #2 among its reported holdings. GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed CVS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)4.82M sh
Reported value held$499.13M
Portfolio Weight9.54%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GLENVIEW CAPITAL MANAGEMENT, LLC's CVS position evolved

GLENVIEW CAPITAL MANAGEMENT, LLC first disclosed a stake in CVS in Q4 2023 at 746,144 shares (US$58.9M). The position peaked in Q1 2025 at 11,946,799 shares, worth US$809.4M. Across 11 filings, GLENVIEW CAPITAL MANAGEMENT, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 4,824,799 shares valued at US$499.1M — a reduction of -3,372,000 shares quarter over quarter.. Notable position changes include a 127% increase in Q1 2024 (shares fell 25% over the following quarter), a 440% increase in Q2 2024 (shares rose 8% over the following quarter), a 41% trim in Q2 2026 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 746.14K $58.92M New
Q1 2024 1.70M $135.31M Add
Q2 2024 9.16M $541.13M Add
Q3 2024 11.95M $751.21M Add
Q4 2024 11.95M $536.29M Hold
Q1 2025 11.95M $809.40M Hold
Q2 2025 8.20M $565.42M Reduce
Q3 2025 8.20M $617.96M Hold
Q4 2025 8.20M $650.50M Hold
Q1 2026 8.20M $588.69M Hold
Q2 2026 4.82M $499.13M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has GLENVIEW CAPITAL MANAGEMENT, LLC held CVS?

GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed CVS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is GLENVIEW CAPITAL MANAGEMENT, LLC's current position in CVS?

As of Q2 2026, GLENVIEW CAPITAL MANAGEMENT, LLC holds 4.82M shares of CVS (CVS HEALTH CORP), valued at $499.13M, representing 9.54% of its reported portfolio and ranking #2.

Has GLENVIEW CAPITAL MANAGEMENT, LLC been buying or selling CVS?

In the latest 13F filing (Q2 2026), GLENVIEW CAPITAL MANAGEMENT, LLC reduced its position in CVS. The position peaked in Q1 2025 at 11.95M shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.